We recently announced some changes to our business model supported by the data coming out of our ongoing Phase 1 clinical trial.

To expand on our announcement, we hosted a live Fireside Chat. In this intimate conversation with key Imagion Biosystems team members, we covered: 

• A discussion on what this means for Imagion Biosystems
• An update on the future of our technology
• Answered frequently asked questions
• Participant Q&A session

Speaker | Robert Proulx, President & CEO

Speaker | Yalia Jayalakshmi, PhD, Chief Development Officer

Moderator | Geoff Hollis, CFO & Company Secretary

The live session has already taken place, but you may request a recording of this webinar by filling out the form.